J. Charrier

发表

Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry in Clinical Microbiology: What Are the Current Issues?

Jean-Philippe Charrier, Alex van Belkum, Victoria Girard, 2017, Annals of laboratory medicine.

RiboDB Database: A Comprehensive Resource for Prokaryotic Systematics.

M. Gouy, S. Penel, C. Brochier-Armanet, 2016, Molecular biology and evolution.

Rapid Bacterial Identification, Resistance, Virulence and Type Profiling using Selected Reaction Monitoring Mass Spectrometry

F. Vandenesch, H. Rostaing, L. Véron, 2015, Scientific Reports.

Rapid detection of carbapenemase activity: benefits and weaknesses of MALDI-TOF MS

A. van Belkum, A. Belkum, J. Charrier, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Method for determination of protein disulfide isomerase for in vitro diagnosis of colorectal cancer

J. Charrier, D. Rolland, Corinne Beaulieu, 2008 .

Label-free SRM-based relative quantification of antibiotic resistance mechanisms in Pseudomonas aeruginosa clinical isolates

J. Schrenzel, T. Köhler, S. Chatellier, 2015, Front. Microbiol..

Selective recognition of enzymatically active prostate‐specific antigen (PSA) by anti‐PSA monoclonal antibodies

G. Deléage, C. Geourjon, Y. Courty, 2005, Journal of molecular recognition : JMR.

Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.

G. Deléage, M. Jolivet, J. Charrier, 2001, The Journal of urology.

An update on the routine application of MALDI-TOF MS in clinical microbiology

Jean-Philippe Charrier, Alex van Belkum, Martin Welker, 2019, Expert review of proteomics.

Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.

G. Deléage, M. Jolivet, J. Charrier, 1999, Clinical chemistry.

Detection of Staphylococcus aureus Delta-Toxin Production by Whole-Cell MALDI-TOF Mass Spectrometry

F. Vandenesch, Y. Benito, S. Boisset, 2012, PloS one.

Impact of Serum and Plasma Matrices on the Titration of Human Inflammatory Biomarkers Using Analytically Validated SRM Assays.

Jean-Philippe Charrier, Sylvie Pons, Tanguy Fortin, 2016, Journal of proteome research.

Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer

E. Cotte, F. Poirier, C. Lambert, 2011, The FEBS journal.

Deciphering Multifactorial Resistance Phenotypes in Acinetobacter baumannii by Genomics and Targeted Label-free Proteomics*

P. Courvalin, X. Lacoux, J. Lemoine, 2017, Molecular & Cellular Proteomics.

Early and specific targeted mass spectrometry-based identification of bacteria in endotracheal aspirates of patients suspected with ventilator-associated pneumonia

M. Ploy, P. Vignon, B. François, 2021, European Journal of Clinical Microbiology & Infectious Diseases.

Analysis of high molecular mass proteins larger than 150 kDa using cyanogen bromide cleavage and conventional 2‐DE

F. Poirier, M. Jolivet, G. Choquet-Kastylevsky, 2008, Electrophoresis.

The current status of clinical proteomics and the use of MRM and MRM3 for biomarker validation

Jean-Philippe Charrier, Jérôme Lemoine, Tanguy Fortin, 2012, Expert review of molecular diagnostics.

Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests

A. Salvador, T. Fortin, C. Lenz, 2009, Molecular & Cellular Proteomics.

Classification of Proteomic MS Data as Bayesian Solution of an Inverse Problem

Pierre Grangeat, Audrey Giremus, Jean-François Giovannelli, 2014, IEEE Access.

Isoelectric point determination of cardiac troponin I forms present in plasma from patients with myocardial infarction.

Jean-Philippe Charrier, Colette Jolivet-Reynaud, J. Charrier, 2007, Clinica chimica acta; international journal of clinical chemistry.

Alternative Representation for the Stability Diagram of Quadrupole Ion Traps upon Additional Quadrupolar Excitation

P. Dugourd, R. Antoine, A. Salvador, 2013, European journal of mass spectrometry.

Two‐dimensional electrophoresis of prostate‐specific antigen in sera of men with prostate cancer or benign prostate hyperplasia

M. Jolivet, P. Dalbon, J. Charrier, 1999, Electrophoresis.

New protein quantification proceeds by mass spectrometry

A. Salvador, T. Fortin, J. Lemoine, 2009 .

An alternative for purification of low soluble recombinant hepatitis C virus core protein: Preparative two‐dimensional electrophoresis

M. Jolivet, J. Charrier, D. Rolland, 1998, Electrophoresis.

Rapid detection of carbapenemase activity: benefits and weaknesses of MALDI-TOF MS

A. van Belkum, A. Belkum, S. Chatellier, 2015, European Journal of Clinical Microbiology & Infectious Diseases.

Bayesian inference for biomarker discovery in proteomics: an analytic solution

Pierre Grangeat, Noura Dridi, Audrey Giremus, 2017, EURASIP J. Bioinform. Syst. Biol..

Differential diagnosis of prostate cancer and benign prostate hyperplasia using two‐dimensional electrophoresis

P. Dalbon, J. Charrier, D. Chautard, 2001, Electrophoresis.

Linear MALDI-ToF simultaneous spectrum deconvolution and baseline removal

J. Giovannelli, P. Grangeat, A. Giremus, 2018, BMC Bioinformatics.

Variable selection for noisy data applied in proteomics

Pierre Grangeat, Noura Dridi, Audrey Giremus, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP).